We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+24%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$385M
AUM Growth
+$89.8M
Cap. Flow
+$11.6M
Cap. Flow %
3.02%
Top 10 Hldgs %
35.04%
Holding
192
New
25
Increased
41
Reduced
78
Closed
6

Top Buys

Rank Stock Value
1
VEEV icon
Veeva Systems
VEEV
+$6.61M
2
NFLX icon
Netflix
NFLX
+$6.39M
3
ABBV icon
AbbVie
ABBV
+$6.08M
4
ABT icon
Abbott
ABT
+$5.42M
5
AKAM icon
Akamai
AKAM
+$5.29M

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$6.27M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$5.9M
3
JPM icon
JPMorgan Chase
JPM
+$5.57M
4
CMCSA icon
Comcast
CMCSA
+$4.85M
5
CPRT icon
Copart
CPRT
+$4.74M

Sector Composition

Rank Sector Weight
1 Healthcare 25.25%
2 Technology 22.34%
3 Consumer Discretionary 11.07%
4 Communication Services 9.13%
5 Consumer Staples 7.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DTF
176
DTF Tax-Free Income 2028 Term Fund
DTF
$81.1M
$160K 0.04%
11,186
NXQ
177
DELISTED
NUVEEN ELECT TAX-FREE INC 2
NXQ
$154K 0.04%
10,155
LUMN icon
178
Lumen
LUMN
$6.44B
$137K 0.04%
13,897
-300
-2% -$3K
NLY icon
179
Annaly Capital Management
NLY
$17.4B
$81K 0.02%
2,788
-125
-4% -$3.09K
USA icon
180
Liberty All-Star Equity Fund
USA
$1.85B
$66K 0.02%
11,200
TCRT icon
181
Alaunos Therapeutics
TCRT
$4.86M
$59K 0.02%
131
LUNA
182
DELISTED
Luna Innovations Incorporated
LUNA
$56K 0.01%
10,054
CMCSA icon
183
Comcast
CMCSA
$90B
-141,009
Closed -$4.85M
CPRT icon
184
Copart
CPRT
$27.5B
-276,620
Closed -$4.74M
CSL icon
185
Carlisle Companies
CSL
$15.4B
-7,730
Closed -$968K
DRI icon
186
Darden Restaurants
DRI
$24.4B
-5,364
Closed -$292K
LHX icon
187
L3Harris
LHX
$53.4B
-34,814
Closed -$6.27M
RTN
188
DELISTED
Raytheon Company
RTN
-4,339
Closed -$569K

Similar funds

Dixon Hubard Feinour & Brown's Q2 2020 Portfolio in Review

As of Q2 2020, Dixon Hubard Feinour & Brown held 192 positions worth $385M, up 30% from $296M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Dixon Hubard Feinour & Brown deployed $11.6M of net new capital in Q2 2020, opening 25 new positions and adding to 41 existing holdings. Its largest new stake was Veeva Systems: 33,309 shares worth $8.36M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $5.9M trimmed.

  • Dixon Hubard Feinour & Brown's largest Q2 2020 buy was Veeva Systems: 33,309 shares worth $8.36M.
  • Dixon Hubard Feinour & Brown added most to AbbVie in Q2 2020, an estimated $6.08M increase.
  • Dixon Hubard Feinour & Brown's biggest Q2 2020 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $5.9M.
  • Dixon Hubard Feinour & Brown fully exited L3Harris in Q2 2020, selling an estimated $6.27M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 35% of its $385M portfolio in Q2 2020.
  • Dixon Hubard Feinour & Brown opened 25 new positions and closed 6 in Q2 2020.
  • Dixon Hubard Feinour & Brown's portfolio value rose 30% quarter-over-quarter to $385M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2020, filed 31 Jul 2020.